Potential of CLSPN as a therapeutic target in melanoma: a key player in melanoma progression and tumor microenvironment
Abstract Background Melanoma is a highly aggressive form of skin cancer. Despite significant advances in targeted therapies and immunotherapeutic approaches, some patients still have poor response rates, making a deeper understanding of melanoma pathogenesis essential. Methods The expression of Clas...
Saved in:
| Main Authors: | Yongyi Xie, Ruoqi Wang, Mingyuan Xu, Jiashe Chen, Wei Tan, Yanbin Chen, Yun Bai, Nanhui Wu, Fei Wu, Xiaoxiang Xu, Xin Ma, Yeqiang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06455-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization
by: Kanta Hori, et al.
Published: (2024-12-01) -
CDKN2A, a key gene in copper-induced cell death model, influencing melanoma invasion and apoptosis
by: Jing Li, et al.
Published: (2025-02-01) -
Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights
by: Lingxia Wu, et al.
Published: (2025-01-01) -
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
by: Luling Xia, et al.
Published: (2025-05-01) -
Integrated bioinformatic analysis identifies GADD45B as an immune-related prognostic biomarker in skin cutaneous melanoma
by: Qing Zhang, et al.
Published: (2025-05-01)